Expanded Dose Exploration in Part A and Dose Escalation in Part B of BEAM-302 Phase 1/2 Study in Alpha-1 Antitrypsin ...
Pfizer has axed 11 programs, including two pipeline assets from its $43 billion Seagen acquisition, work on a ...
The first sickle cell disease patient has been enrolled in a Phase 1b trial testing iadademstat, Oryzon Genomics' ...
SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer ...
Apnimed, Inc., a pharmaceutical company building the industry-leading portfolio of first-in-class oral drug candidates that address the root causes of obstructive sleep apnea (OSA) and other ...
The new provision of Medicaid is set to go into effect by January 1, 2027, which leaves only a year and a half for those on Medicaid to adjust. Although some are exempt from needing to provide proof ...
Kerala Blasters secured all 3 points to solidify their spot on top of Group D as the Tuskers thrashed Sporting Club Delhi by ...
Pociredir Phase 1b PIONEER Trial Data in Sickle Cell Disease to be Presented and Published, Including 12 mg and 20 mg Cohorts ― ...
A Florida developer recently struck a deal with officials in Mooresville, a booming town north of Charlotte. The developer agreed to pay $15 million for a new thoroughfare in exchange ...
The U.S. Department of Agriculture will pay about half of November benefits for the Supplemental Nutrition Assistance Program, or SNAP, though benefits could take months to flow to ...
Reaffirms full-year 2025 Revenue guidance of $61.0 to $64.0 billion. Raises and narrows Adjusted (2) diluted EPS guidance (1) ...
Western Arizona communities have done our part. We've cut water use, invested in conservation, and planned for a future that respects the limits of the Colorado River. Towns like Queen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback